• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞腺瘤内发生的恶性潜能不确定的肝细胞肿瘤或高分化肝细胞癌。

Hepatocellular Neoplasm of Uncertain Potential of Malignancy or Well-Differentiated Hepatocellular Carcinoma Arising within Hepatocellular Adenoma.

作者信息

Campos Elisabete, Silva Roberto, Rodrigues Sara, de Almeida Marinho, Lopes Joanne, Aral Marisa, Cristino Humberto, Graça Luís, Barbosa Elisabete

机构信息

Hepato-Bilio-Pancreatic and Splenic Unit, General Surgery Department, São João University Medical Center, Oporto, Portugal.

Pathology Department, São João University Medical Center, Oporto, Portugal.

出版信息

Case Rep Surg. 2023 Mar 29;2023:2831510. doi: 10.1155/2023/2831510. eCollection 2023.

DOI:10.1155/2023/2831510
PMID:37427296
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10328728/
Abstract

BACKGROUND

Hepatocellular adenoma (HCA) is an uncommon solid, solitary, benign liver lesion that develops in an otherwise normal-appearing liver. Hemorrhage and malignant transformation are the most important complications. Risk factors for malignant transformation include advanced age, male gender, use of anabolic steroids, metabolic syndrome, larger lesions, and beta-catenin activation subtype. The identification of higher risk adenomas enables the selection of patients most suitable for aggressive treatment and those who benefit with surveillance, minimizing the risks for these predominantly young patients. . We present the case of a 29-year-old woman with a history of oral contraceptive intake for 13 years, which was sent to evaluation in our Hepato-Bilio-Pancreatic and Splenic Unit because of a large nodular lesion in segment 5 of the liver, compatible with HCA, and was proposed to surgical resection. Histological and immunohistochemical investigation revealed an area with atypical characteristics, suggesting malignant transformation.

CONCLUSIONS

HCAs share similar imaging characteristics and histopathological features with hepatocellular carcinomas; therefore, immunohistochemical and genetic studies assumes great importance to discriminate adenomas with malignant transformation. Beta-catenin, glutamine synthetase, glypican-3, and heat-shock protein 70 are promising markers to identify higher risk adenomas.

摘要

背景

肝细胞腺瘤(HCA)是一种罕见的实性、孤立性良性肝脏病变,发生于外观正常的肝脏。出血和恶变是最重要的并发症。恶变的危险因素包括高龄、男性、使用合成代谢类固醇、代谢综合征、较大的病变以及β-连环蛋白激活亚型。识别高风险腺瘤有助于选择最适合积极治疗的患者以及适合进行监测的患者,从而将这些主要为年轻患者的风险降至最低。我们报告一例29岁女性病例,该患者有13年口服避孕药史,因肝脏第5段出现一个与HCA相符的大结节性病变,被送至我们的肝胆胰脾科进行评估,并建议手术切除。组织学和免疫组化检查发现一个具有非典型特征的区域,提示恶变。

结论

HCA与肝细胞癌具有相似的影像学特征和组织病理学特征;因此,免疫组化和基因研究对于鉴别恶变腺瘤非常重要。β-连环蛋白、谷氨酰胺合成酶、磷脂酰肌醇蛋白聚糖-3和热休克蛋白70是识别高风险腺瘤的有前景的标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ff2/10328728/fe538ca95749/CRIS2023-2831510.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ff2/10328728/55cbb3c55148/CRIS2023-2831510.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ff2/10328728/f44f686fc5e9/CRIS2023-2831510.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ff2/10328728/95ce55e61f4e/CRIS2023-2831510.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ff2/10328728/1f8bde6685d8/CRIS2023-2831510.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ff2/10328728/44fe1cf5c072/CRIS2023-2831510.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ff2/10328728/fe538ca95749/CRIS2023-2831510.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ff2/10328728/55cbb3c55148/CRIS2023-2831510.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ff2/10328728/f44f686fc5e9/CRIS2023-2831510.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ff2/10328728/95ce55e61f4e/CRIS2023-2831510.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ff2/10328728/1f8bde6685d8/CRIS2023-2831510.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ff2/10328728/44fe1cf5c072/CRIS2023-2831510.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ff2/10328728/fe538ca95749/CRIS2023-2831510.006.jpg

相似文献

1
Hepatocellular Neoplasm of Uncertain Potential of Malignancy or Well-Differentiated Hepatocellular Carcinoma Arising within Hepatocellular Adenoma.肝细胞腺瘤内发生的恶性潜能不确定的肝细胞肿瘤或高分化肝细胞癌。
Case Rep Surg. 2023 Mar 29;2023:2831510. doi: 10.1155/2023/2831510. eCollection 2023.
2
Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.肝细胞腺瘤的分子分类与危险因素、出血和恶性转化相关。
Gastroenterology. 2017 Mar;152(4):880-894.e6. doi: 10.1053/j.gastro.2016.11.042. Epub 2016 Dec 7.
3
Hepatocellular adenomas in the Turkish population: reclassification according to updated World Health Organization criteria.土耳其人群中的肝细胞腺瘤:根据世界卫生组织最新标准进行重新分类。
Histopathology. 2021 Jul;79(1):23-33. doi: 10.1111/his.14330. Epub 2021 Apr 12.
4
Hepatocellular adenomas: review of pathological and molecular features.肝细胞腺瘤:病理和分子特征综述。
Hum Pathol. 2021 Jun;112:128-137. doi: 10.1016/j.humpath.2020.11.016. Epub 2020 Dec 9.
5
Long-term Evolution of Hepatocellular Adenomas at MRI Follow-up.MRI 随访中肝细胞腺瘤的长期演变。
Radiology. 2020 May;295(2):361-372. doi: 10.1148/radiol.2020191790. Epub 2020 Mar 17.
6
Applying criteria for hepatocellular neoplasm of uncertain malignant potential reclassifies more than half of hepatocellular adenomas.应用不确定恶性潜能的肝细胞肿瘤标准,可使超过一半的肝细胞腺瘤重新分类。
Ann Diagn Pathol. 2021 Dec;55:151833. doi: 10.1016/j.anndiagpath.2021.151833. Epub 2021 Sep 25.
7
A rare case of hepatocellular carcinoma arising from gadoxetate-retaining hepatic adenoma.一例罕见的源自钆塞酸滞留型肝腺瘤的肝细胞癌。
Radiol Case Rep. 2019 Nov 27;15(2):141-143. doi: 10.1016/j.radcr.2019.10.030. eCollection 2020 Feb.
8
Malignant transformation of liver fatty acid binding protein-deficient hepatocellular adenomas: histopathologic spectrum of a rare phenomenon.肝脂肪酸结合蛋白缺陷型肝细胞腺瘤的恶性转化:一种罕见现象的组织病理学谱。
Mod Pathol. 2020 Apr;33(4):665-675. doi: 10.1038/s41379-019-0374-x. Epub 2019 Sep 30.
9
Changing trends in malignant transformation of hepatocellular adenoma.肝细胞腺瘤恶变的变化趋势。
Gut. 2011 Jan;60(1):85-9. doi: 10.1136/gut.2010.222109.
10
A Shifting Paradigm in Diagnosis and Management of Hepatic Adenoma.肝腺瘤的诊断与治疗范式转变
Ann Surg Oncol. 2020 Sep;27(9):3330-3338. doi: 10.1245/s10434-020-08580-w. Epub 2020 Jun 15.

引用本文的文献

1
Case Report: Hepatocellular adenoma due to long-term oral stanozolol administration.病例报告:长期口服司坦唑醇导致肝细胞腺瘤。
Front Med (Lausanne). 2025 Aug 20;12:1654316. doi: 10.3389/fmed.2025.1654316. eCollection 2025.

本文引用的文献

1
Applying criteria for hepatocellular neoplasm of uncertain malignant potential reclassifies more than half of hepatocellular adenomas.应用不确定恶性潜能的肝细胞肿瘤标准,可使超过一半的肝细胞腺瘤重新分类。
Ann Diagn Pathol. 2021 Dec;55:151833. doi: 10.1016/j.anndiagpath.2021.151833. Epub 2021 Sep 25.
2
Hepatocellular Carcinomas: Towards a pathomolecular approach.肝细胞癌:走向病理分子方法。
Liver Int. 2021 Jun;41 Suppl 1:83-88. doi: 10.1111/liv.14867.
3
Predictive Patterns of Glutamine Synthetase Immunohistochemical Staining in CTNNB1-mutated Hepatocellular Adenomas.
CTNNB1 突变型肝细胞腺瘤中谷氨酰胺合成酶免疫组化染色的预测模式。
Am J Surg Pathol. 2021 Apr 1;45(4):477-487. doi: 10.1097/PAS.0000000000001675.
4
Hepatocellular carcinoma arising from hepatic adenoma in a young woman.一名年轻女性中由肝腺瘤引发的肝细胞癌。
Clin Case Rep. 2020 May 27;8(9):1659-1662. doi: 10.1002/ccr3.2975. eCollection 2020 Sep.
5
Guidelines for the Treatment of Hepatocellular Adenoma in the Era of Molecular Biology: An Experience-Based Surgeons' Perspective.基于分子生物学的肝细胞腺瘤治疗指南:基于经验的外科医生视角。
J Gastrointest Surg. 2021 Jun;25(6):1494-1502. doi: 10.1007/s11605-020-04724-1. Epub 2020 Jul 14.
6
Optimizing small liver biopsy specimens: a combined cytopathology and surgical pathology perspective.优化小肝活检标本:细胞病理学与外科病理学的联合视角。
J Am Soc Cytopathol. 2020 Sep-Oct;9(5):405-421. doi: 10.1016/j.jasc.2020.05.014. Epub 2020 Jun 10.
7
Long-term Evolution of Hepatocellular Adenomas at MRI Follow-up.MRI 随访中肝细胞腺瘤的长期演变。
Radiology. 2020 May;295(2):361-372. doi: 10.1148/radiol.2020191790. Epub 2020 Mar 17.
8
Utility of rapid on-site evaluation for needle core biopsies and fine-needle aspiration cytology done for diagnosis of mass lesions of the liver.快速现场评估在用于肝脏肿块病变诊断的粗针活检和细针穿刺细胞学检查中的应用价值。
J Am Soc Cytopathol. 2019 Mar-Apr;8(2):69-77. doi: 10.1016/j.jasc.2018.08.001. Epub 2018 Aug 16.
9
Atypical Hepatocellular Neoplasms: Review of Clinical, Morphologic, Immunohistochemical, Molecular, and Cytogenetic Features.非典型肝细胞肿瘤:临床、形态、免疫组化、分子和细胞遗传学特征综述。
Adv Anat Pathol. 2018 Jul;25(4):254-262. doi: 10.1097/PAP.0000000000000189.
10
Extrahepatic metastasis of hepatocellular carcinoma arising from a hepatic adenoma without concurrent intrahepatic recurrence.源于肝腺瘤的肝细胞癌的肝外转移,无同时性肝内复发。
Curr Oncol. 2017 Aug;24(4):e333-e336. doi: 10.3747/co.24.3494. Epub 2017 Aug 31.